FDA Inspection 972159 — Zhejiang Tiantai Pharmaceutical Co., Ltd. (Cangshan Plant)
The FDA completed an inspection of Zhejiang Tiantai Pharmaceutical Co., Ltd. (Cangshan Plant) on Mar 24, 2016 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 24, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)